Skip to main content

GE HealthCare Technologies Inc. (GEHC) Stock Analysis

SellModerate Confidence

Healthcare · Medical Devices

Sell if holding. Momentum 3.6/10 is below the 5.0 floor at $60.86 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Geographic: non-U.S. revenue; V7 low-quality RISK_OFF penalty: -0.5 (Q=5.1).

GE HealthCare is a global medical technology company offering imaging, ultrasound, patient care solutions, and pharmaceutical diagnostics to hospitals, clinics, and life science customers in 160+ countries. It earns revenue through equipment sales, services, and recurring... Read more

$60.86+18.4% A.UpsideScore 5.3/10#28 of 40 Medical Devices
QualityF-score6 / 9FCF yield6.21%
IncomeYield0.23%Payout4.20%sustainable
Stop $56.99Target $71.95(analyst − 10%)A.R:R 2.4:1
Analyst target$79.95+31.4%19 analysts
$71.95our TP
$60.86price
$79.95mean
$98

Sell if holding. Momentum 3.6/10 is below the 5.0 floor at $60.86 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Geographic: non-U.S. revenue; V7 low-quality RISK_OFF penalty: -0.5 (Q=5.1). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 5.3/10, moderate confidence.

Passes 6/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, earnings proximity 74d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: moderate.

Recent Developments — GE HealthCare Technologies Inc.

Generated 2026-05-20T21:06:21Z.

Thesis

Rewards
Sector modifier (Healthcare): +0.5
Strong earnings beat streak (3/4)
Attractive valuation
Risks
Concentration risk — Geographic: non-U.S. revenue
V7 low-quality RISK_OFF penalty: -0.5 (Q=5.1)
Weak growth

Key Metrics

P/E (TTM)14.6
P/E (Fwd)11.3
Mkt Cap$27.6B
EV/EBITDA10.3
Profit Mgn9.1%
ROE19.5%
Rev Growth7.4%
Beta0.87
Dividend0.23%
Rating analysts28

Quality Signals

Piotroski F6/9MoatNarrow

Options Flow

P/C0.66bullish
IV42%normal

Concentration Risks(10-K Item 1A)

  • HIGHGeographicnon-U.S. revenue
    10-K Item 1A: 'We generate the majority of our revenue outside of the U.S.'

Material Events(8-K, last 90d)

  • 2026-03-17Item 5.02LOW
    GE HealthCare appointed Monish Lobo to its Board of Directors, effective March 17, 2026.
    SEC filing →
  • 2026-02-26Item 1.02MEDIUM
    GE HealthCare terminated its 2025 364-Day Revolving Credit Agreement, which was replaced by a new 2026 364-Day Revolving Credit Agreement providing a $1.0B revolving credit facility maturing February 25, 2027.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth
0.0
Revenue Growth
4.3

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Ma Position
1.0
Volume
1.7
Rsi
3.0
Obv
5.2
Macd
7.3
Capitulation risk (RSI 27, below 200MA)Below 200-MA, MA slope -1.4%/30d — confirmed downtrend
GatesMomentum 3.6<4.5Death cross (50MA < 200MA)A.R:R 2.4 ≥ 1.5Insider activity: OKNo SEC red flagsEARNINGS PROXIMITY 74d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Moderate
RSI
27 · Oversold
20D MA 50D MA 200D MADEATH CROSSSupport $58.75Resistance $75.18

Price Targets

$57
$72
A.Upside+18.2%
A.R:R2.4:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeRisk-Off

Risk Alerts

! Momentum score 3.6/10 — below 4.5 minimum
! Death cross — 50-day MA below 200-day MA

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-07-29 (74d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is GEHC stock a buy right now?

Sell if holding. Momentum 3.6/10 is below the 5.0 floor at $60.86 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Geographic: non-U.S. revenue; V7 low-quality RISK_OFF penalty: -0.5 (Q=5.1). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $56.99. Score 5.3/10, moderate confidence.

What is the GEHC stock price target?

Take-profit target: $71.95 (+18.4% upside). Prior stop was $56.99. Stop-loss: $56.99.

What are the risks of investing in GEHC?

Concentration risk — Geographic: non-U.S. revenue; V7 low-quality RISK_OFF penalty: -0.5 (Q=5.1); Weak growth.

Is GEHC overvalued or undervalued?

GE HealthCare Technologies Inc. trades at a P/E of 14.6 (forward 11.3). TrendMatrix value score: 7.4/10. Verdict: Sell.

What do analysts say about GEHC?

28 analysts cover GEHC with a consensus score of 3.9/5. Average price target: $80.

What does GE HealthCare Technologies Inc. do?GE HealthCare is a global medical technology company offering imaging, ultrasound, patient care solutions, and...

GE HealthCare is a global medical technology company offering imaging, ultrasound, patient care solutions, and pharmaceutical diagnostics to hospitals, clinics, and life science customers in 160+ countries. It earns revenue through equipment sales, services, and recurring consumable and software contracts with a focus on AI-enabled precision care.

Related stocks: GMED (Globus Medical, Inc.) · DXCM (DexCom, Inc.) · PODD (Insulet Corporation) · BSX (Boston Scientific Corporation) · ZBH (Zimmer Biomet Holdings, Inc.)